Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuhiro Kajikawa

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Molecular Therapy. Methods & Clinical Development|September 8, 2017
Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human PrimatesTetsuhiro Kajikawa, Ruel A Briones, Ranillo R G Resuello, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 20, 2026
DEL-1 is an Endogenous Senolytic Protein that Inhibits Senescence-Associated Bone LossJong-Hyung Lim, Kridtapat Sirisereephap, Hui Wang, et al.
Journal of Clinical Periodontology|January 6, 2016
Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3Tomoki Maekawa, Ruel A Briones, Ranillo R G Resuello, et al.
The Journal of Clinical Investigation|August 21, 2020
The DEL-1/β3 integrin axis promotes regulatory T cell responses during inflammation resolutionXiaofei Li, Alessandra Colamatteo, Lydia Kalafati, et al.
The Journal of Clinical Investigation|February 8, 2022
Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulationTheresa Failer, Michael Amponsah-Offeh, Aleš Neuwirth, et al.
Science Translational Medicine|October 19, 2018
A dysbiotic microbiome triggers T<sub>H</sub>17 cells to mediate oral mucosal immunopathology in mice and humansNicolas Dutzan, Tetsuhiro Kajikawa, Loreto Abusleme, et al.
The Journal of Clinical Investigation|August 29, 2017
Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell nicheIoannis Mitroulis, Lan-Sun Chen, Rashim Pal Singh, et al.
Clinical Immunology (Orlando, Fla.)|September 16, 2018
Safety profile after prolonged C3 inhibitionEdimara S Reis, Nadja Berger, Xin Wang, et al.
Nature Immunology|November 21, 2018
DEL-1 promotes macrophage efferocytosis and clearance of inflammationIoannis Kourtzelis, Xiaofei Li, Ioannis Mitroulis, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Molecular Therapy. Methods & Clinical Development|September 8, 2017
Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human PrimatesTetsuhiro Kajikawa, Ruel A Briones, Ranillo R G Resuello, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 20, 2026
DEL-1 is an Endogenous Senolytic Protein that Inhibits Senescence-Associated Bone LossJong-Hyung Lim, Kridtapat Sirisereephap, Hui Wang, et al.
Journal of Clinical Periodontology|January 6, 2016
Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3Tomoki Maekawa, Ruel A Briones, Ranillo R G Resuello, et al.
The Journal of Clinical Investigation|August 21, 2020
The DEL-1/β3 integrin axis promotes regulatory T cell responses during inflammation resolutionXiaofei Li, Alessandra Colamatteo, Lydia Kalafati, et al.
The Journal of Clinical Investigation|February 8, 2022
Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulationTheresa Failer, Michael Amponsah-Offeh, Aleš Neuwirth, et al.
Science Translational Medicine|October 19, 2018
A dysbiotic microbiome triggers T<sub>H</sub>17 cells to mediate oral mucosal immunopathology in mice and humansNicolas Dutzan, Tetsuhiro Kajikawa, Loreto Abusleme, et al.
The Journal of Clinical Investigation|August 29, 2017
Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell nicheIoannis Mitroulis, Lan-Sun Chen, Rashim Pal Singh, et al.
Clinical Immunology (Orlando, Fla.)|September 16, 2018
Safety profile after prolonged C3 inhibitionEdimara S Reis, Nadja Berger, Xin Wang, et al.
Nature Immunology|November 21, 2018
DEL-1 promotes macrophage efferocytosis and clearance of inflammationIoannis Kourtzelis, Xiaofei Li, Ioannis Mitroulis, et al.
Pageof 3